• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY; PERIPHERALLY INSERTED CENTRAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY; PERIPHERALLY INSERTED CENTRAL CATHETER Back to Search Results
Model Number 45889
Medical Device Problem Codes Difficult to Remove (1528); Material Twisted/Bent (2981)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/17/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was reported that the device is not available to be returned to the manufacturer for evaluation.The results of the investigation will be sent via a follow up medwatch.Reference: (b)(4).
 
Event or Problem Description
An angiodynamics territory manager reported an issue with the nitinol guidewire in a bio-stable 5f dl 55cm mst-70 kit.The patient was cannulated and the wire was inserted, both with no difficulty.When the provider went to pull off the needle, the guidewire was stuck at the needle hub, so, she then tried to remove the introducer sheath and guidewire together with no success, which would result in losing vein access.A doctor was called to assist and it was determined to perform a cut down to remove the guidewire.The physician had to make an incision that was a couple of centimeters to retrieve guidewire.Once removed, the guidewire was observed to have a knot at distal tip and could not be retracted out of introducer.The incision did not require sutures to close.It was determined to place the picc in the patient's other arm, in which a bard guidewire was used.The patient did not experience any adverse effects, harm, or require medical intervention because of this incident.It was indicated that the reported device is not available to be returned to the manufacturer for evaluation.
 
Additional Manufacturer Narrative
As the reported device was not returned, angiodynamics is unable to perform a device evaluation.The reported complaint description could not be confirmed as the reported guidewire was not returned for evaluation.A root cause for the reported event could not be determined.A potential root cause of this type of guidewire knot issue is handling damage during use due to end user technique, i.E.Quick advancement against an obstruction.A review of the device history records was performed for the indicated lots for any deviations related to the reported failure mode of the complaint.The review confirms that the lots met all material, assembly and performance specifications; i.E.No ncr associated with reported failure mode.Labeling review: the dfu that is supplied in bioflo kits contains the following precaution: it is recommended that only luer lock accessories be used with the · bioflo¿ picc with endexo¿ and pasv¿ valve technology.Repeated over-tightening may reduce hub connector life.Do not use hemostats to secure or remove devices with luer lock hub connections.Flushing - recommended procedure 1.Flush the catheter after every use, or at least every seven days when not in use, to maintain patency.Use a 10 ml syringe or larger.2.Flush the catheter with a minimum of 10 ml of sterile normal saline, using a "pulse" or "stop/start" technique.Warn ing: if using bacteriostatic saline, do not exceed 30 ml in a 24-hour period.3.Disconnect the syringe and attach a sterile end cap to each luer lock hub.Note: this is the recommended flush procedure for this catheter.If using a different procedure than listed above, the use of heparin may be necessary.Follow institutional protocol for catheter flushing.Precaution: incompatible drug delivery within the same lumen may cause precipitation.Ensure that the catheter lumen is flushed following each infusion.Precaution: if resistance is met when flushing, it is recommended that no further attempts be made.Further flushing may result in catheter rupture.Refer to institutional protocol for clearing occluded catheters.Precaution: place a cap on the hub after use to reduce the risk of contamination.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4)correction: section b1: initial report had both product problem and adverse event marked.Only product problem should have been marked.Section d3: upn updated, lot number and mfg date added section h4: mfg date added.
 
Event or Problem Description
Additional information provided reported the initial part number was incorrect.The correct upn and the lot number of the product was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY
Common Device Name
PERIPHERALLY INSERTED CENTRAL CATHETER
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls, ny 12801 NY 12801
MDR Report Key12204985
Report Number1317056-2021-00128
Device Sequence Number19202697
Product Code LJS
UDI-Device IdentifierH965458890
UDI-PublicH965458890
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K121089
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2021
Device Model Number45889
Device Catalogue Number45812
Device Lot Number5538028
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/24/2021
Supplement Date Received by Manufacturer09/29/2021
Initial Report FDA Received Date07/21/2021
Supplement Report FDA Received Date09/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age20 YR
-
-